Coronavirus | AstraZeneca rejects reports on vaccine efficacy in elderly

Updated - January 26, 2021 11:31 pm IST

Published - January 26, 2021 10:13 pm IST - Berlin

Germany’s Health Ministry on Tuesday joined AstraZeneca in rubbishing reports quoting unnamed government sources that claimed the British-Swedish company’s Covid-19 vaccine showed little efficacy for people above 65.

Handelsblatt daily had reported on Monday that Berlin had estimated that the efficacy of the jab in people above 65 was just 8%, citing unnamed sources. Separately, Bild daily, quoting anonymous sources, put the efficacy rate at “less than 10%”.

But Germany’s Health Ministry said it appears that there have been some mix up in the reports.

“Around 8% of the volunteers in AstraZeneca’s efficacy studies were around 56 and 69 years old and three to 4% are above 70 years old,” said the Ministry.

“However, this does not mean that it is effective only in 8% of older people,” it added.

The company has also rejected the media reports on its vaccine efficacy in adults over 65 years as “completely incorrect”.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.